• Publications
    Expected Returns Articles
  • Research
    Companies Funds Top 40 My Studies
  • Stock Screen
    New Stock Screen Manage Screens
  • Dashboards
    My Dashboards New Dashboard
  • Forum
  • Events
  • Search
  • Contact Us
  • Sign In

Funds & Featured Portfolios

  • « First
  • ‹ Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next ›
  • Last »
Fund Analysis: Hoard vs. Herds by Cy Lynch Dec 01, 2010

Accumulate Nasdaq-100 (QQQQ).

Fund Analysis: Hoard vs. Herds by Cy Lynch Nov 01, 2010

Accumulate Nasdaq-100 (QQQQ).

Fund Analysis: Hoard vs. Herds by Mark Robertson Oct 01, 2010

Accumulate M* Wide Moat Focus (WMW).

Hoard vs. Herds: WMW by Mark Robertson Sep 01, 2010

Accumulate Morningstar Wide Moat (WMW).

Hoard vs. Herds: QQQQ by Cy Lynch Aug 01, 2010

The average selection for the Hoard has outperformed the total stock market benchmark by +12.6% during its holding period. Accuracy stands at 68% due to some lagging healthcare positions.

iShares Morningstar Large Growth Index by Cy Lynch Jul 01, 2010

Larger companies continue to provide better overall potential returns relative to their smaller peers. With MIPAR moving back above 10%, it's especially prudent to improve portfolio growth, while not compromising quality.

Pharmaceutical HOLDRs by Cy Lynch Jun 01, 2010

Patient investors should be especially rewarded if analysts' current expectations are overly negative.

iShares Morningstar Large Growth Index by Cy Lynch May 01, 2010

The Hoard's relative return since inception is +6.7% based on its total return of 34.3% versus 27.6% for the Herd during the same period.

Hoard vs. Herds by Mark Robertson Apr 01, 2010

Add iShares M* Large Growth Index.

ELEMENTS Morningstar Wide Moat Focus by Cy Lynch Mar 01, 2010

WMW is first of all funds covered according to the MANIFEST Ranking based on a combination of projected return, quality and actual relative return.

ELEMENTS Morningstar Wide Moat Focus by Cy Lynch Feb 01, 2010

WMW's holdings include equal weightings of the 20 best values of all stocks that Morningstar determines have wide-moats.

ELEMENTS Morningstar Wide Moat Focus ETN by Mark Robertson Jan 01, 2010

WMW brought home a stellar return for 2009 but it should prove to be more than a one-hit wonder.

Hoard vs. Herds by Mark Robertson Dec 01, 2009

Accumulate DJ US Medical Devices.

Hoard vs. Herds by Mark Robertson Nov 01, 2009

Buy DJ US Medical Devices (IHI).

Hoard vs. Herds by Mark Robertson Oct 01, 2009

Sell OBEGX, Buy VUG and VEU.

Mutual Fund Selection by Mark Robertson Sep 01, 2009

VHT is a three-time selection during 2009 -- as health-related stocks continue to be under adverse pressure stemming from the uncertainty surrounding legislative impact on the healthcare industry.

Vanguard Staples by Mark Robertson Aug 01, 2009

VDC is a passively-managed sector exchange-traded fund. The addition of VDC continues to bolster overall portfolio quality while not compromising overall returns .

T. Rowe Price Health & Science by Cy Lynch Jul 01, 2009

PRHSX is an actively managed fund concentrating on health related companies. It provides a solid quality portfolio selected by management with an excellent track record.

Jensen by Mark Robertson Jun 01, 2009

JENSX reads like a Who’s Who of blue chip high-quality stocks that are frequently of interest to our community of long-term investors..

Vanguard Healthcare by Mark Robertson May 01, 2009

VHT is a passively managed ETF focusing on a sub-set of companies in the healthcare sector.

iShares DJ US Healthcare Provider by Cy Lynch Apr 01, 2009

IHF is a passively managed ETF focusing on a sub-set of companies in the healthcare sector.

Oberweis Emerging Growth by Mark Robertson Mar 01, 2009

The challenges facing retirement plan investors don’t appear to be getting any easier. Discovering a reliable mutual fund and achieving superior returns continues to be elusive.

Oberweis Emerging Growth by Mark Robertson Feb 01, 2009

OBEGX is a recipe for some smaller, promising companies.

Funds: Hoard vs. Herd by Mark Robertson Jan 01, 2009

Starting with this issue, we're converting the fund section to another "nest egg" demonstration, maintained as a model portfolio using the MANIFEST tools and resources.

NASDAQ-100 QQQ by Cy Lynch Dec 01, 2008

With QQQQ a repeat pick, we'll review our ETF Sector Radar, highlighting how it influenced our selection of QQQQ.

© 2006 - 2025 Manifest Investing. All rights reserved.
About | Terms of Service | Disclaimer | Privacy Policy

Legend
Quality Legend:
Blue Excellent with quality greater than 80.
Green Good with quality between 60 and 80.
Neutral Average or below average with quality between 20 and 60.
Red Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green PAR is within the target range of MIPAR +5-10%, currently 5.1%-10.1%
Yellow PAR is above the target range of MIPAR +10%, currently 10.1%
PAR Projected Annual Return
MIPAR The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
* Not covered by Value Line Standard Edition.
b Uses price-to-book value for valuation purposes.
P/CF Uses price-to-cash flow for valuation.